A carregar...
Targeting β-amyloid pathology in Alzheimer’s disease with Aβ immunotherapy
More than 10 clinical trials of Aβ immunotherapy are currently underway in patients with Alzheimer’s disease (AD). The aim is to identify safe approaches for the efficacious antibody-mediated removal of brain β-amyloid or its neurotoxic oligomeric precursors consisting of aggregated amyloid β-peptid...
Na minha lista:
| Publicado no: | Neurotherapeutics |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer-Verlag
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084243/ https://ncbi.nlm.nih.gov/pubmed/18625453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2008.05.013 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|